MedPath

Feasibility study of combined aerobic exercise and strength training during neoadjuvant chemotherapy for resectable adenocarcinoma of the stomach or gastroesophageal junction.

Not Applicable
Not yet recruiting
Conditions
locally advanced adenocarcinoma of the stomach or gastroesophageal junction (AEG I-III)
C16
Malignant neoplasm of stomach
Registration Number
DRKS00005607
Lead Sponsor
Klinikum rechts der Isar der TU München
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

1.) Histologically verified, resectable Adenocarcinoma of the stomach or the esophageal-gastric-junction (AEG I-III), stage uT2 - uT4 without distant metastases.
2.) age = 18 years
3.) 3.) ECOG Status 0-2
4.) negative pregnancy test for women of childbearing-potential
5.) Sufficient bone-marrow, hepatic and renal function by assessment of the treating oncologist

Exclusion Criteria

1.) non-resectable primary tumour by assessment of the treating surgeon.
2.) Participation in an interventional trial with interefering primary endpoint.
3.) pregnancy or breat-feeding
4.) severe cardiac comorbidities (instable angina pectoris, congestive heat failure NYHA IV, malignent arteriell Hypertension).
5.) severe pulmonary comorbidities (COPD GOLD IV)
6.) Muscoloskeletall comorbidities (e.g. coxarthritis, Gonarthritis) that significantly limit mobility
7.) lack of compliance
8.) other reasons that impede physical exercise training

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative Morbidity and Mortality according to Dindo-Clavien Grade II-IV
Secondary Outcome Measures
NameTimeMethod
1.) number of patients enrolled within the recruiting period<br>2.) number of screened patients<br>3.) Number of patients that finish the exercise training (compliance)<br>4.) drop-out rate
© Copyright 2025. All Rights Reserved by MedPath